title: Gestational trophoblastic disease and human chorionic gonadotropin measurement.
abstract: Improved radioimmunometric assays for the glycoprotein human chorionic gonadotropin, its whole molecule and free beta and alpha subunits have improved the capability for trophoblast tumor detection and monitoring. New heights in survival rates have been reached with these improvements, particularly in high-risk disease.
authors.affiliation: Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee.
authors.forename: R A
authors.initials: RA
authors.lastname: Pattillo
authors.forename: R O
authors.initials: RO
authors.lastname: Hussa
mesh_terms: D006063:Chorionic Gonadotropin / Q000032:analysis*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011863:Radioimmunoassay; D014328:Trophoblastic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000628:therapy
chemical_list: D006063:Chorionic Gonadotropin